| 2025-10-27 |
详情>>
内部人交易：
ZANTE GREG等共交易10笔
|
| 2025-10-23 |
详情>>
股本变动：
变动后总股本11303.63万股
|
| 2025-10-23 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.8美元,归母净利润-2.02亿美元,同比去年增长-170.94%
|
| 2025-10-22 |
财报披露：
美东时间 2025-10-22 盘后发布财报
|
| 2025-07-23 |
详情>>
业绩披露：
2025年中报每股收益-0.99美元,归母净利润-1.11亿美元,同比去年增长-124.15%
|
| 2025-04-24 |
详情>>
业绩披露：
2025年一季报每股收益-0.41美元,归母净利润-4562.9万美元,同比去年增长-66.8%
|
| 2025-04-08 |
股东大会：
将于2025-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class I directors to serve until our 2028 Annual Meeting of Stockholders: Matthew W. Foehr and Charles A. Rowland, Jr.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益-1.01美元,归母净利润-1.1亿美元,同比去年增长-28.02%
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益-0.9美元,归母净利润-6886.7万美元,同比去年增长-25.24%
|
| 2024-10-23 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.69美元,归母净利润-7454.6万美元,同比去年增长-21.63%
|
| 2024-07-24 |
详情>>
业绩披露：
2023年中报每股收益-0.44美元,归母净利润-3875.6万美元,同比去年增长-15.57%
|
| 2024-07-24 |
详情>>
业绩披露：
2024年中报每股收益-0.46美元,归母净利润-4960.6万美元,同比去年增长-28%
|
| 2024-04-25 |
详情>>
业绩披露：
2024年一季报每股收益-0.26美元,归母净利润-2735.6万美元,同比去年增长-40.06%
|
| 2024-04-05 |
股东大会：
将于2024-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class III directors to serve until our 2027 Annual Meeting of Stockholders: Brian Lian, Ph.D. and Lawson Macartney, DVM, Ph.D.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve the Viking Therapeutics, Inc. 2024 Equity Incentive Plan;
5.To approve the Viking Therapeutics, Inc. 2024 Employee Stock Purchase Plan;
6.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2024-02-07 |
详情>>
业绩披露：
2023年年报每股收益-0.91美元,归母净利润-8589.5万美元,同比去年增长-24.73%
|
| 2023-10-25 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.66美元,归母净利润-6129万美元,同比去年增长-24.3%
|
| 2023-05-01 |
股东大会：
将于2023-06-13召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class II directors to serve until our 2026 Annual Meeting of Stockholders: J. Matthew Singleton and S. Kathy Rouan, Ph.D.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve an amendment to our amended and restated certificate of incorporation (the “Charter”) to reflect new Delaware law provisions regarding officer exculpation;
5.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2022-04-07 |
股东大会：
将于2022-05-24召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class I directors to serve until our 2025 Annual Meeting of Stockholders: Matthew W. Foehr and Charles A. Rowland, Jr.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-08 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class III directors to serve until our 2024 Annual Meeting of Stockholders: Brian Lian, Ph.D. and Lawson Macartney, DVM, Ph.D.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021;
3.To approve, on an advisory basis, the compensation of our named executive officer;
4.To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers;
5.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2020-04-06 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class II directors to serve until our 2023 Annual Meeting of Stockholders: J. Matthew Singleton and S. Kathy Rouan, Ph.D.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020;
3.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2019-04-05 |
股东大会：
将于2019-05-23召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class I directors to serve until our 2022 Annual Meeting of Stockholders: Matthew W. Foehr and Charles A. Rowland, Jr.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2019;
3.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-09-18 |
复牌提示：
2018-09-18 07:00:13 停牌，复牌日期 2018-09-18 07:35:00
|
| 2018-04-06 |
股东大会：
将于2018-05-24召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class III directors to serve until our 2021 Annual Meeting of Stockholders: Brian Lian, Ph.D. and Lawson Macartney, DVM, Ph.D.;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2018;
3.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-04-07 |
股东大会：
将于2017-05-23召开股东大会
会议内容 ▼▲
- 1.To elect the following nominees as Class II directors to serve until our 2020 Annual Meeting of Stockholders: Mr. J. Matthew Singleton and Mr. Stephen W. Webster;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2017;
3.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2016-04-12 |
股东大会：
将于2016-05-26召开股东大会
会议内容 ▼▲
- 1.To elect the following nominee as a Class I director to serve until our 2019 Annual Meeting of Stockholders: Mr. Matthew W. Foehr;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016;
3.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|